There have been many important developments in hypertension since the last multidisciplinary conference in 1996. We now know more about the value of antihypertensive treatment and have increasing evidence in favour of both the calcium channel blockers and the ACE inhibitors.
A ruling by the European Union heralds the demise of those useful clinical instruments, the mercury thermometer and the mercury sphygmomanometer. The new laws have been passed because of worries about mercury poisoning. Yet you can drink metallic mercury and come to no harm. What does it all mean?
There are three forms of mercury from the toxicological point of view: inorganic mercury salts such as mercuric chloride; organic mercury compounds, however, remain some anxiety on the use of shortacting calcium channel blockers in patients with existing coronary heart disease.
The angiotensin receptor antagonists have proved immensely successful and in March 1997 the first long term trial of losartan was published (the ELITE study). This showed that losartan was as good as or slightly better than captopril in the management of elderly patients with heart failure. It is significant that a great many other drugs in this class are being developed by other drug companies. There is increasing evidence that blocking the renin-angiotensin system has added benefits over other drug therapies in delaying the progression of renal failure in both diabetics and non-diabetics with nephropathy and also in reducing left ventricular hypertrophy. There is also one interesting study which suggests that the ACE inhibitors delay the development of retinopathy in diabetic patients.
A great many trials are now being established to investigate the benefits of the 'new' versus the 'old' drugs in hypertension. In particular the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT) is ending its pilot phase. There will however be relatively little new information on the treatment of hypertension until well into the next century. such as dimethylmercury, which are very fat soluble; and metallic mercury, which is only absorbed into the body as the vapour.
Inorganic mercury salts are water soluble, irritate the gut, and can cause severe kidney damage. Organic mercury compounds, which are fat soluble, cross from the blood into the brain, and cause intellectual impairment, damage to the optic nerves, and ataxia. There can also be peripheral nerve damage.
Mercury metal poses two dangers. It can be vapor-ised: the vapour pressure (the amount of vapour 'given off') at room temperature is about 100 times the safe amount. As mercury metal is heated, it evaporates more readily, and the vapour pressure doubles for every 10°C rise in temperature. This makes heating mercury, especially in a confined space, very dangerous. Even at room temperature, poisoning can occur if mercury metal is spilled into crevices or cracks in the floorboards of a poorly ventilated room. Dentists are occasionally poisoned in this way. Mercury vapour, being fat soluble, easily crosses into the brain, and causes tremor, depression, and a behavioural disturbance called erethism. In addition, the vapour causes mouth ulcers and salivation. A second danger from metallic mercury is that it
Validated patient self-measurement of blood pressure verifies hypertension and optimises its management RS Armstrong, JP Taylor, M Stowasser and RD Gordon
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Patient self-measurement of blood pressure optimises management through providing comprehensive, accurate information and by promoting patient compliance and involvement in the management of their condition. Self-measurement also enables the progress of geographically remote patients to be followed. Assessment, education and continuing follow-up however are essential to provide valid, standardised measurements and reasonably ensure user and device accuracy.
Patients view an instructional video either on the hospital video system or at the Hypertension Nurse's office. Viewing is followed by demonstration and practice with the nurse instructor using a dual or three way stethoscope. Accuracy is confirmed prior to leaving and patients take home written instructions and a simplified checklist. A 2-week later follow-up visit to ensure proper technique and promote patient confidence is arranged and further 6-monthly checks of device and patient technique are encouraged.
Aneroid gauges are checked by comparing randomly selected points on the gauge against the mercury column. Electronic devices are connected with a Y piece to the mercury and a series of six simultaneous same arm measurements are taken on the person who uses the device for self-measurement. Validity is also promoted by obtaining multiple readings under standardised conditions over a short The measurement of blood pressure (BP) is a crucial part of clinical assessment and hypertension management and is commonly performed inaccurately despite the publication of national and international consensus guidelines for its measurement. A postal is turned into organic mercury, for example by bacteria in the sludge at the bottom of lakes. The bacteria concentrate the organic mercury, and are eaten by marine creatures that are themselves eaten by fish higher up the chain, until the fish are eaten by humans. Environmental contamination by metallic mercury from chemical plants, its subsequent organification, and the concentration of poisonous organic mercury in fish, lead to the Japanese tragedy at Minimata Bay in the late 1950s when over 800 people were poisoned. A number were children in utero.
It is the need to reduce mercury contamination of the environment which should encourage us to cut the usage of metallic mercury. However, much more metallic mercury is spilled as waste by the chemical industry than is dropped on the floor in the clinic.
period of time. Self-measurement verifies hypertension by excluding white coat hypertension and quantifying the white coat effect. Patients can take frequent measurements at times not normally readily obtainable and thus contribute more comprehensive information with regard to 24-h control and optimal distribution of medication.
Management is optimised by patient self-measurement because the measurement is more consistent and accurate than what is provided by many health professionals. Because the patient feels more in control, compliance is improved. By excluding the white coat effect, lower doses can be administered with confidence with fewer side effects and a better quality of life. The chronotherapuetic approach to management using self-measured blood pressures can facilitate optimal use of medication and result in reduced cost for individual and health budgets.
Patient self-measurement, because of its repeatability without aid of health professional staff for each period of measurement, is more cost effective than office blood pressure measurement or 24 h ambulatory monitoring.
In these days of accountability and cost valued ahead of outcome by government agencies, the reduced cost to the patient and the community at the same time as patient care is improved, must be almost unique.
questionnaire survey was conducted of 831 community-based practitioners (550 general practitioners and 281 practice nurses) in north west London.
The response rate was 61%. Overall the nurses (n = 196) had a greater knowledge base than the GPs (n = 320) and both community groups had a greater knowledge for key questions than hospital practitioners from two previous surveys. Nurse practitioners (n = 17) and GPs involved in teaching in postgraduate education programmes (n = 69) had better knowledge than their respective peer groups. The nurse practitioners scored best overall. Knowledge of a guideline source was associated with improved self-reported BP technique. Previous education in BP measurement was recorded in 87% of the GPs and 95% of the nurses which is higher than surveys of hospital practitioners. Precision factors recorded for the GPs and nurses respectively included routine use of diastolic phase V (GP 60%, nurse 66%), reading the BP to Joint National Committee on Prevention, Detection, Evaulation and Treatment of High Blood Pressure (JNC VI)
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The National High Blood Pressure Education Program (NHBPEP), co-ordinated by the National Heart, Lung, and Blood Institute (NHLBI) 1,2 of the National Institutes of Health, is succeeding in its mission of increasing awareness, prevention, treatment, and control of hypertension. The most recent national data, however, indicate disturbing decreases in rates of hypertension awareness, prevention, treatment and control.
The purpose of the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) is to provide guidance for primary care clinicians. Using evidence-based medicine and consensus, the report updates contemporary approaches to hypertension control for use by primary care physicians. The JNC VI report places more emphasis than earlier reports on absolute risk and benefit and uses risk stratification as part of the treatment strategy. This report strongly encourages lifestyle modification to prevent blood pressure, as definitive therapy for some, and as adjunctive therapy for all persons with hypertension. In addition, the major emphasis is placed on selection of appropriate pharmacologic therapy.
Among other issues briefly covered are the cost of health care, the use of self-measurement of blood Joint National Guidelines on Coronary Heart Disease Prevention in the UK: implications for hypertension In 1994 the European Societies of Cardiology, Atherosclerosis and Hypertension published recommendations on the prevention of coronary heart disease in clinical practice. This collaboration between professional societies was intended to the nearest 2 mm mercury (GP 53%, nurse 67%) and correctly reporting the rate of fall of the mercury column (GP 27%, nurse 55%). Most said they had access to a large cuff (GP 98%, nurse 93%), but significant numbers had not used it in the past 4 weeks (GP 33%, nurse 24%) and few knew the correct coverage of the upper arm circumference (GP 27%, nurse 32%). Only 12% of the GPs and 19% of the nurses were able to name the source of the published guidelines on BP measurement.
These results show that there are important differences in the knowledge-base of BP measurement between different community practitioners. The proportion who can name a source of BP measurement guidelines is disappointingly low but these practitioners do have a better knowledge-base.
pressure, the role of managed care in the treatment of high blood pressure, the introduction of new combination antihypertensive medications and angiotensin II receptor blockers, and strategies for improving adherence to treatment.
The prevention and treatment of hypertension represent major public health challenges for the United States as we enter the new millennium. The new challenges identified are:
• to prevent the rise of blood pressure with age;
• decrease the existing prevalence of hypertension;
• increase hypertension awareness and detection;
• improve control of hypertension, reduce cardiovascular risks; • increase recognition of the importance of controlled isolated systolic hypertension; • improve recognition of the importance of highnormal blood pressure; • reduce ethnic, socio-economic, and regional variations in hypertension; • improve opportunities for treatment; and • enhance community programmes.
References
1 NHLBI website at www.nhlbi.nih.gov/nhlbi/nhlbi.htn 2 NHLBI Information Center at 1-800-575-9355 encourage national societies to follow suit and produce locally relevant guidelines. Hence the British Cardiac Society, British Hyperlipidaemia Association and the British Hypertension Society decided in 1996 to produce Joint British Recommendations on Prevention of Coronary Heart Disease in Clinical Practice. This document will be finalised in the summer of 1998 and is expected to appear as a supplement to Heart later this year. A much shorter, more easily digested version will be produced later in 1998 and distributed by the British Heart Foundation.
The objective of the document was simply to encourage a unified approach towards the reduction of first time or further cardiac events and reduce overall morality. The document prioritises preventive efforts to:
(1) patients with established CHD; (2) patients with other major atherosclerotic disease; (3) patients with various risk factors (eg, hypertension) which put them at high risk of developing CHD or other atherosclerotic disease.
It was felt necessary to produce such a document because of increasing trial evidence in recent years which has strengthened our understanding of the effectiveness of various therapeutic interventions for preventing CHD, and because hitherto there has been a strong tendency for professional isolation in clinical practice whereby a patient with angina may well be under the care of specialists in cardiology, hypertension, lipids and diabetes all in the same hospital. Each of the specialists tends to deal with their own risk factor in isolation of the others and by doing so overlooks the other major determinants of a patient's progress. The document therefore recommends a broader
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There are very few drugs, if any, which produce an absolutely consistent antihypertensive response such that the magnitude of the blood pressure (BP) reduction is wholly consistent throughout the full 24 hours. Instead, at some time after dosing there will be a period of maximum pharmacological activity and thereby a period of maximal BP reduction which will typically occur at 2 or 4 or 6 h post-dose. To identify and quantify this 'peak' effect it is therefore necessary to take account of the level of BP which would be present if no antihypertensive drug had been administered, ie, following placebo administration. Thus, it is necessary to have an assessment of the BP under placebo conditions across the dosing interval, which may be 12 or 24 h in routine practice, to directly compare the measured BP response on active treatment and to then subtract this value from the BP values obtained with placebo.
The timing of the trough BP measurement, in contrast to the more variable timing of the peak BP response, is strictly defined as the end of the dosage interval. This obviously will be immediately prior multifactorial approach to the management of each risk factor including hypertension.
In the context of primary prevention it recommends that a level of absolute risk is calculated for high risk patients on the basis of a risk score, based largely on the Framingham Study. The score includes: age; sex; systolic blood pressure (SBP); diastolic blood pressure (DBP); total cholesterol; HDL-cholesterol; diabetes (yes/no); smoking (yes/no); and ECG-LVH. A computerised disc to calculate coronary heart disease (CHD) risk in the next 10 years is provided with the recommendations, but for those not wishing to use a computer, a chart similar to that produced in the New Zealand Guidelines will be produced.
The treatment algorithm for hypertension is summarised in the figure. to the time of the next dose being taken and it will be 24 h post-dose with a once daily regimen and 12 h post-dose with a twice daily regimen.
The concept of the trough:peak ratio was derived from FDA guidelines which were concerned not only about the suitability of antihypertensive drugs for their recommended dosage intervals but also about patient safety if excessive BP reductions were produced. Thus, the administration of high doses sufficient to cause hypotensive effects at peak was not permissible if the sole aim was the prolongation of the antihypertensive effect to the end of the dosage interval.
There are additional practical considerations in terms of a high trough:peak ratio. The FDA set a minimum requirement to 50-66% but the closer the value approaches 100% then the greater is the consistency of the antihypertensive response throughout its dose interval: ie, across 24 h with a once daily drug. The Second National Australian Blood Pressure Study (ANBP2) is a cardiovascular outcome trial of the treatment of hypertension in the elderly. Six thousand hypertensive patients aged between 65-84 years will be randomised to receive treatment based on an angiotensin-converting enzyme (ACE) inhibitor or a diuretic-based regimen and monitored for total cardiovascular events over a 5-year period.
Conclusions
The study is being conducted entirely in general practice in and around five Australian capital cities. At the onset there were several areas which required consideration if this study was to be successful.
The first challenge in implementing ANBP2 was to identify general practitioners willing to take part and therefore willing to allow access to patient files and also willing to have hypertensive patients withdrawn from antihypertensive therapy for a period of time prior to recommencement of therapy according to the study protocol.
Second, would patients be willing to participate in such a study and finally could we realistically hope to implement this protocol in the general practice setting while maintaining high quality of data collection, given the enormous variability of practice environments and cultures and the spread of The British Regional Heart Study: a prospective study of cardiovascular disease in 24 towns The British Regional Heart Study aims to explain the regional variation in ischaemic heart disease and stroke rates which have a 2 to 3-fold range across Great Britain, highest in the north-west and lowest in the south-east.
In 1978-1980, 7735 men aged 40-59 years were recruited from GP age-sex registers in 24 towns and examined by a team of three nurses to obtain a full cardiovascular risk factor profile. All men have been followed up through their GP for CVD morbidity and through the National Health Service Central Registers for mortality.
Blood pressure was measured using the London School of Hygiene sphygmomanometer and each nurse carried out one-third of each of the procedures in each town. Despite the use of training tapes, interobserver variation occurred and this has been adjusted for in the analyses. A marked increase was quently: values approximating to 100% indicate a satisfactory and consistent (ie, non-fluctuating) antihypertensive effect throughout the whole 24 hours. population across Australian cities and rural centres?
ANBP2's research nurses are involved in all stages of the project from GP recruitment to subject randomisations. Once the GP has registered it falls to the research nurse to foster a collaborative environment within each practice enabling successful subject recruitment.
There are 102 nurses registered with ANBP2 and by 30 June 1998 approximately 55 000 subjects will have been screened yielding 6000 randomised patients. This has been possible through the participation of 1938 general practitioners working within 962 practices throughout Australian city and rural centres.
Already the subject monitoring process is underway and it is expected that December 2001 will see the completion of this second phase.
The role of the research nurse has been pivotal to the successful establishment and conduct of this nationwide project and I would like to further discuss specific protocol issues in consideration of the general practice setting and its general practice clientele.
found in the mean blood pressure measurements made on Mondays compared with Fridays.
The geographic variation in town mean blood pressure is consistent with the geographic variation in cardiovascular mortality rates. An increase in mean blood pressure of 1 mm Hg produces an approximate 2% increase in the prevalence of hypertensives (systolic blood pressure [SBP] Ͼ160 mm Hg). Factors which contribute to raising blood pressure, such as age, alcohol consumption, body mass index (BMI), and social class only partially explain these town variations.
Heart attacks occur twice as often in men with a SBP Ͼ148 mm Hg compared with those whose SBP is less than 148 mm Hg. Whereas strokes occur four times more often in men with SBPs above 160 mm Hg.
Contrary to widespread belief smoking status does not raise blood pressure, but increases CVD risk by a factor of two. The independent effects of smoking and hypertension interact to increase stroke risk by 12-fold, compared with non-smoking normotensives. Physical activity appears to have a modest beneficial effect on blood pressure, apart from a small increase in levels in the very vigorously active men. Moderate daily physical activity reduces the risk of heart attacks and strokes by 50%, but hypertensive men who are vigorously active incur a slightly higher risk of heart attacks. Objectives To study the influence of diet, demographic factors, body mass and physical fitness on blood pressure (BP) levels in children from the general community and to relate changes in BP to data recorded over an extended period.
Western Australian longitudinal study of heart health
Design and methods This is a longitudinal study commenced in 1985 with a cohort of 1565 children aged 9 years resurveyed every 3 years. Measurements included BP, height, weight, total cholesterol, anthropometry, fitness testing and questionnaires relating to diet, lifestyle, attitudes and health beliefs, family history and physical activity. DNA samples were obtained in the most recent survey. Parents were invited to attend in 1996-1998 for BP measurements to validate previous family history questionnaires.
Results
Of the 1565 eligible participants 1066 were seen in 1985, 1311 in 1988, 694 in 1991 and 669 in 1994 . Cardiovascular risk factors were related to health behaviours of individuals and differed within families. Systolic blood pressure (SBP) was positively related to weight, smoking and alcohol intake and negatively to energy intake, fitness and birthweight. Total cholesterol was positively associated with waist-hip ratio and negatively with fitness. Adverse dietary patterns and physical inac- The management of hypertension in children has been rather neglected, with only limited information on the current clinical practice. To investigate this further, we conducted a postal survey of 1500 paediatricians in the United Kingdom, of whom 706 (47.1%) provided analysable replies. Only 50.7% of respondents routinely measured out-patient blood pressures themselves: 16.7% measured blood pressures from birth, 11.6% from age 1, 21.7% from age 3, 11.3% from age 7 and 3.3% from age 13; 29.6% did not routinely measure blood pressure in an outFrom a later study of treatment practice, in a national sample of GPs, it was found that they are failing to treat the older age groups adequately in line with British Hypertension Society guidelines.
The detection and treatment of hypertension in paediatric practice
The study continues to follow the 6000 survivors and is currently re-examining them 20 years after their baseline measurements. Response rates at rescreening so far range between 75-86% in the towns.
tivity were particularly associated with lower socioeconomic status in girls. Longitudinal analysis showed that BP was greater in boys with hypertensive fathers and that BP increased more rapidly in this group. Children of overweight parents had lower levels of fitness throughout the period of the surveys, ate less fibre and more saturated fat. In longitudinal models, body mass index (BMI) from the age of 9 to 18 years was consistently greater in offspring of overweight parents and BMI in 18 years olds was significantly predicted additively by father's and mother's BMI. The study has also highlighted associations between adverse health behaviours with smoking as a key indicator of clustering of risk behaviours.
Conclusions
These observations have important implications for health promotion in young people. There is potential for identifying, at an early age, individual children and groups of children who are most at risk of becoming hypertensive adults. Parental hypertension and overweight should alert health professionals to the potential risk for children, indicating the need to improve health behaviours in families although genetic factors may contribute. Our data suggest that recognition of children at risk can lead to reduction in levels of risk factors during childhood and adolescence and through to adulthood. patient. The majority measured blood pressures whilst the child is sitting (57.6%) or supine (17.6%), usually with a mercury sphygmomanometer (81.4%); only 13.2% used ambulatory blood pressure devices. When measuring diastolic blood pressures, 49.3% used Korotkof phase IV, whilst 30.2% used phase V: 10.8% would consider a child as hypertensive if the blood pressure was Ͼ90th percentile, 34.8% used the 95th percentile and 37.8% used the 97.5th percentile. Most would perform urea and electrolytes (91.6%), urinalysis (92.5%) and full blood count (81.2%) as basic or initial tests in a hypertensive child, although Ͼ65% would check urate levels, an ECG or perform a renal ultrasound. A total of 59.2% routinely referred to blood pressure charts/normograms in the interpretation of blood pressure results, usually that from the 2nd Task Background Because mortality tends to be higher in Scotland than in England for cancer, coronary heart disease and stroke, the Scottish Office commissioned the Scottish Health Survey (SHS) to be modelled on the Health Survey for England (HSE) for comparison. The SHS was conducted in 1995 by the same unit that conducts the HSE. The following analysis is based on 1995 SHS and 1994 HSE data. Nearly all questionnaires were identical for the two surveys.
Blood pressure levels While the prevalence of any cardiovascular disorder was higher in Scotland than in England for both men and women aged 45-64 years, blood pressure levels appear to be lower. Both mean systolic blood pressure (SBP) and mean diastolic blood pressure (DBP) were lower in Scotland than in England across all age groups for both men and women. One reason for this may be differences in treatment and control rates for hypertension between the two countries.
Treatment for hypertension High blood pressure in both the SHS and the HSE was defined as hypertensives (SBP у160 or DBP у95 mm Hg), either treated or untreated, and normotensives (SBP Ͻ160 and DBP Ͻ95) who had been treated. Looking at the proportion of those with survey-defined high blood pressure who had been treated, 64% of men with high blood pressure in Scotland had been given treatment, compared with 52% in England. Seventyfour percent of women with high blood pressure in
The Health Survey for England as a monitoring tool This presentation will illustrate the use of the Health Survey for England (HSE) as a monitoring tool which, together with investigating the determinants of health in the population, is one of the aims of the HSE.
The distribution of adults' blood pressure (BP), the prevalence of high BP using data from the latest available survey (1996) , and trends over time since 1991 will be examined. blockers (33.8%), diuretics (26.6%) or calcium antagonists (7.6%).
This survey provides an insight into blood pressure management amongst British paediatricians, and suggests a wide variation in treatment strategies and prescribing habits. Further guidelines are needed to achieve a consensus strategy for such patients.
Scotland had been given treatment, compared with 63% in England.
Controlling hypertension In terms of how successful each country had been in actually controlling hypertension with treatment, in Scotland, 75% of men and 86% of women who were being treated for hypertension had SBP of less than 160 mm Hg and DBP of less than 95 mm Hg compared with 71% of men and 74% of women in England.
Other risk factors Both men and women in Scotland were more likely to be current cigarette smokers than those in England, with most of the difference concentrated in those aged 45-64 years. Also, both male and female smokers in Scotland were more likely than those in England to report smoking 20 or more cigarettes a day.
A larger proportion of respondents in Scotland reported doing no moderate or vigorous activity in the past week, and respondents in Scotland generally reported eating a less healthy diet than those in England.
Geometric mean fibrinogen was much higher in Scotland than in England for all age groups and was statistically significant for both men and women after adjusting for age. Higher levels of fibrinogen in Scotland were not altered when cigarette smoking status was adjusted for.
Conclusion
Unless the high prevalence of cardiovascular disease in Scotland begins to drop due to effective control of hypertension, the effect of fibrinogen warrants further examination. The HSE is an annual survey that covers the population living in private households; data collection includes a visit by an interviewer, and a subsequent nurse visit, where details of prescribed medications are collected, BP and a number of other measurements taken.
BP is measured using an automated device, the Dinamap 8100 monitor. Three BP readings are taken under standardised conditions on the right arm with the informant in a seated position after 5 min rest. The data analysed are based on the mean of the second and third measurements made on respondents with three recordings completed.
Adult informants are classified in one of four groups on the basis of their systolic and diastolic BP (SBP/DBP) and current use of antihypertensive medication. Normotensive treated, hypertensive treated and hypertensive untreated are referred to as 'hypertensive'.
SBP and DBP generally increased with age, and were higher in men than in women. The prevalence of high BP also increased with age, and was higher in men than in women up to age 45-54, while in the older age groups, the opposite was true.
One of the primary aims of the survey is to examine any changes in mean SBP and high BP over time. Methods A comprehensive search for leaflets was performed and leaflets obtained from a variety of sources including voluntary organisations, pharmaceutical companies and the Internet. Leaflets were randomly allocated to three pairs of doctors from the Birmingham Clinical Effectiveness Group and scored independently. A random selection of the leaflets was given to a fourth pair with previous experience. A scoring system was devised using recognised criteria and marks allocated for content, writing style, design and readability (FOG score). 14 explained lifestyle factors that may contribute to hypertension. 12 made it clear that treatment is long term. 6 put hypertension in the context of overall cardiovascular risk. 13 leaflets had a mean score of 11.5 or less (2 leaflets could not be scored because the text was not continuous).
ward trend in mean SBP. The 1995 and 1996 surveys have not recorded any further downward movement. Nevertheless, age-adjusted mean SBP level in 1996 was significantly below that observed in 1991 in both sexes. There is no evidence of a trend in the prevalence of high BP. As in previous years of the Health Survey since 1993, the treatment rate was defined as the proportion of those with survey defined high BP who were taking antihypertensive medication. The control rate was defined as the proportion of those taking antihypertensive medication who had SBP less than 160 mm Hg and DBP less than 95 mmHg.
Among all adults with high BP, the treatment rate increased. A similar increase in the treatment rate was seen for men and women separately. For the control rate there was no clear trend.
Nurse counselling in general practice for lifestyle modification
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Counselling can be described as 'providing advice' or as 'an exchange of opinions to decide or plan something'. Using either description many 'lay counsellors' have derived the basis for their counselling on myths or traditions. Whereas in the field of hypertension, patient counselling is based on the results of systematic evidence obtained from clinical trials. Evidence-based medicine has also proven the value of focusing on high risk groups to achieve the early detection and treatment of high blood pressure. Additionally it is postulated that if we are proactive in modifying lifestyles rather than reactively responding to disease outcomes the normal distribution of blood pressure (BP) could be universally shifted downward to decrease the epidemic. Given the high percentage of the population who visit their general practitioner each year it is suggested that registered nurses working in or attached to general practice settings are ideally based to target lifestyle modification. Early research into lifestyle modification for patients with high BP using a cognitive behavioural model will be presented. This research targeted weight reduction, smoking cessation, reduction of dietary fat and salt, increasing daily leisure time physical activity, and reducing alcohol intake to recommended guidelines. Results enabled a grant to be obtained to pursue further investigation with high risk groups. The model focused on counselling skills and used simple tools and strategies which were included in a patient manual developed to strengthen the counselling approach. A structured framework for counselling was developed based on the concepts of self efficacy, motivational interviewing and Prochaska and DiClemente's Stage of Change Model. With the move of nursing education to the tertiary sector nurses are better able to conduct or collaborate in qualitative or quantitative research activities. A cognitive behavioural approach to lifestyle modification includes verbal and non-verbal communication skills. With time, resources and training nurses can be assisted to work as effective counsellors.
